Universitätsklinikum Aachen (UKA)

Detection of microcalcifications in spiral breast computed tomography with photon-counting detector is feasible: A specimen study (2021) Wetzl M, Wenkel E, Balbach E, Dethlefsen E, Hartmann A, Emons J, Kuhl C, et al. Journal article CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study (2021) Just KS, Dormann H, Freitag M, Schurig M, Böhme M, Steffens M, Scholl C, et al. Journal article Update Breast Cancer 2021 Part 2-Advanced Stages, Long-Term Consequences and Biomarkers (2021) Ditsch N, Stickeler E, Behrens A, Belleville E, Fasching P, Fehm TN, Hartkopf AD, et al. Journal article, Review article Update Breast Cancer 2021 Part 1-Prevention and Early Stages (2021) Stickeler E, Aktas B, Behrens A, Belleville E, Ditsch N, Fasching P, Fehm TN, et al. Journal article, Review article Seeing faces, when faces can't be seen: Wearing portrait photos has a positive effect on how patients perceive medical staff when face masks have to be worn (2021) Wiesmann M, Franz C, Sichtermann T, Minkenberg J, Mathern N, Stockero A, Iordanishvili E, et al. Journal article EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy (2021) Leichsenring J, Vladimirova V, Solbach C, Karn T, Ataseven B, Sinn B, Barinoff J, et al. Conference contribution BACH1 and HIF1 alpha predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC) (2021) Vladimirova V, Schneeweiss A, Jackisch C, Weber KE, Denkert C, Schmatloch S, Karn T, et al. Conference contribution Epigenetic regulation of the putative breast cancer metastasis suppressor gene SCN4B (2021) Hilgers L, Hartmann A, Fasching P, Villwock S, Moll L, Roger S, Knuechel-Clarke R, et al. Conference contribution Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from pd-l1 inhibition in women with early triple-negative breast cancer (2021) Sinn BV, Loibl S, Hanusch CA, Zahm DM, Sinn HP, Untch M, Weber K, et al. Journal article Loss-of-function mutations of bcor are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia (2021) Eckardt JN, Stasik S, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, et al. Journal article